AGSP257, National AMR Funded by Susceptibility N. gonorrhoeae n/a Website; 258 (reference surveillance DoHA testing of quarterly and laboratories of N. annual all Australian against reports to single-dose and New regimens of Diseases Zealand) penicillins, Intelligence; ceftriaxone, also reports ciprofloxacin annually on and WPR and SEAR high-level Gonococcal resistance to Antimicrobial tetracyclines Surveillance and Programme intermittent surveys of 2007/08) azithromycin HISWA116 Western HAI Funded by Hospital Susceptibility Surgical site MRSA, Website; Australia surveillance WA testing and infections, VRE individual (public government molecular central line, and hospital hospitals and and typing haemodialysis C. reports and private PathWest; infections; S. aggregate healthcare managed by aureus reports; rates facilities) HAIU at the (MRSA/MSSA), stratified by bloodstream specimen site Disease infections, and patient Control MRSA and C. location Directorate difficile infections
AGSP257, 258 National (reference laboratories of all Australian and New Zealand) AMR surveillance Funded by DoHA Susceptibility testing of N. against single-dose regimens of penicillins, ceftriaxone, ciprofloxacin and high-level resistance to tetracyclines and intermittent surveys of azithromycin N. gonorrhoeae n/a Website; quarterly and annual reports to Diseases Intelligence; also reports annually on WPR and SEAR Gonococcal Antimicrobial Surveillance Programme 2007/08) HISWA116 Western Australia (public hospitals and private healthcare facilities) HAI surveillance Funded by WA government and PathWest; managed by HAIU at the Disease Control Directorate Hospital Susceptibility testing and molecular typing Surgical site infections, central line, haemodialysis infections; S. aureus (MRSA/MSSA), bloodstream infections, MRSA and C. difficile infections MRSA, VRE and C. Website; individual hospital reports and aggregate reports; rates stratified by specimen site and patient location
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx